Neurology
RSSArticles
-
Prevention and Risk Factor Reduction
These articles are based on the editor's personal interactions as a participant at the International Stroke Conference in Houston, Feb. 22-24, 2017. All interpretations and opinions are exclusively those of the editor.
-
Clinical Briefs
In this section: soothing dementia with music; the gastrointestinal tract and cardiology; NSAIDs might pose cardiovascular risks.
-
Deflazacort Tablets and Suspension (Emflaza)
Deflazacort is indicated for the treatment of Duchenne muscular dystrophy in patients ≥ 5 years of age.
-
Antibiotic Treatment in Community-acquired Pneumonia
In patients with newly diagnosed community-acquired pneumonia, basing the duration of antibiotic treatment on clinical stability criteria led to a significant reduction in duration of antibiotic treatment without an increased risk of adverse outcomes.
-
Helping Disabled Patients Through Physical Activity
Recent trial demonstrated that a structured physical activity intervention reduces reported severe mobility disability and difficulty on mobility tasks, but not all disability in older adults who experience functional limitations.
-
Benefit of Bariatric Surgery for Obesity and Diabetes Maintained After Five Years
It seems that for an individual patient, clinicians now can discuss the pros and cons of bariatric surgery compared with aggressive medical management with a fair bit of certainty about expected outcomes.
-
Contraception, Migraines, and Stroke
In this case-control study, women with migraines with aura using combined hormonal contraception had six times the odds of experiencing ischemic stroke compared to women without migraines not using combined hormonal contraception. Use of combined hormonal contraception among women with migraines without aura was not associated with an increased risk of stroke over baseline.
-
Are There Definitive Clues?
How certain are you that the run of wide complex tachycardia that begins with beat #4 is ventricular tachycardia?
-
Clinical Briefs
In this section: targeting the culprit of obesity; a skeptical look at urinalysis; and comparing treatments for peripheral artery disease.
-
Etelcalcetide Injection (Parsabiv)
Etelcalcetide is indicated for secondary hyperparathyroidism in adult patients presenting with chronic kidney disease and who are on hemodialysis.